Without an update to the Privacy Act, a tracking of disclosures will be required each time the VA sends information to the PDMP or accesses this PDMP. This an unreasonable request given the high volume of use of these medications and will greatly undermine the intent of sharing vital information. As well as the ability of the VA to ensure the save and effective use of these potentially dangerious medications
Comment on AO45-Interim Final Rule-Gardner, Bryan J.
This is comment on Rule
AO45 - Interim Final Rule - Disclosures To Participate in State Prescription Drug Monitoring Programs
View Comment
Related Comments
Public Submission Posted: 03/20/2013 ID: VA-2013-VHA-0005-0004
Apr 12,2013 11:59 PM ET
Public Submission Posted: 03/20/2013 ID: VA-2013-VHA-0005-0003
Apr 12,2013 11:59 PM ET
Public Submission Posted: 04/15/2013 ID: VA-2013-VHA-0005-0005
Apr 12,2013 11:59 PM ET